{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:44:44Z","timestamp":1791333884573,"version":"4.3.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["15-15-00072-\\u041F"],"award-info":[{"award-number":["15-15-00072-\\u041F"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH P01AI138949"],"award-info":[{"award-number":["NIH P01AI138949"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["522003007"],"award-info":[{"award-number":["522003007"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.cmi.2019.07.026","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T19:46:06Z","timestamp":1565379966000},"page":"513.e1-513.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men"],"prefix":"10.1016","volume":"26","author":[{"given":"J.","family":"Koetsveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Platonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kuleshov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wagemakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hoornstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Szekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.L.A.","family":"van Duijvendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fikrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Embers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sprong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.07.026_bib1","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3201\/eid1710.101474","article-title":"Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia","volume":"17","author":"Platonov","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.026_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1099\/00207713-45-4-804","article-title":"Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan","volume":"45","author":"Fukunaga","year":"1995","journal-title":"Int J Syst Bacteriol"},{"key":"10.1016\/j.cmi.2019.07.026_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pt.2015.03.008","article-title":"Borrelia miyamotoi: a widespread tick-borne relapsing fever spirochete","volume":"31","author":"Wagemakers","year":"2015","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.cmi.2019.07.026_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7326\/M15-0333","article-title":"Borrelia miyamotoi disease in the northeastern United States: a case series","volume":"163","author":"Molloy","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2019.07.026_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(13)61644-X","article-title":"A\u00a0case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe","volume":"382","author":"Hovius","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.07.026_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa1209039","article-title":"Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient","volume":"368","author":"Gugliotta","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.07.026_bib7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3201\/eid2209.152034","article-title":"Borrelia miyamotoi-associated neuroborreliosis in immunocompromised person","volume":"22","author":"Boden","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.026_bib8","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.4049\/jimmunol.1600014","article-title":"Variable major proteins as targets for specific antibodies against Borrelia miyamotoi","volume":"196","author":"Wagemakers","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2019.07.026_bib9","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1128\/jcm.34.10.2483-2492.1996","article-title":"GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis","volume":"34","author":"Schwan","year":"1996","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.07.026_bib10","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1128\/JCM.37.12.3990-3996.1999","article-title":"Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE","volume":"37","author":"Liang","year":"1999","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.07.026_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12879-016-1468-4","article-title":"The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis","volume":"16","author":"Leeflang","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.026_bib12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/374395","article-title":"Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates","volume":"187","author":"Bacon","year":"2003","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.026_bib13","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.9778\/cmajo.20170070","article-title":"Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011\u20132014: a cross-sectional study","volume":"5","author":"Kadkhoda","year":"2017","journal-title":"CMAJ Open"},{"key":"10.1016\/j.cmi.2019.07.026_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.diagmicrobio.2016.06.015","article-title":"Insights into Borrelia miyamotoi infection from an untreated case demonstrating relapsing fever, monocytosis and a positive C6 Lyme serology","volume":"86","author":"Sudhindra","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.026_bib15","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3201\/eid2409.180806","article-title":"Borrelia miyamotoi disease in an immunocompetent patient, western Europe","volume":"24","author":"Hoornstra","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.026_bib16","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/cid\/cix1023","article-title":"Seroreactivity to the C6 peptide in Borrelia miyamotoi infections occurring in the northeastern United States","volume":"66","author":"Molloy","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.026_bib17","doi-asserted-by":"crossref","first-page":"1338 e1","DOI":"10.1016\/j.cmi.2018.03.009","article-title":"Serodiagnosis of Borrelia miyamotoi disease by measuring antibodies against GlpQ and variable major proteins","volume":"24","author":"Koetsveld","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.07.026_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00535-17","article-title":"In\u00a0vitro susceptibility of the relapsing fever spirochete Borrelia miyamotoi to antimicrobial agents","author":"Koetsveld","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.07.026_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00419-18","article-title":"In\u00a0vitro antimicrobial susceptibility of clinical isolates of Borrelia miyamotoi","volume":"62","author":"Koetsveld","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.07.026_bib20","doi-asserted-by":"crossref","first-page":"D190","DOI":"10.1093\/nar\/gkw1107","article-title":"InterPro in 2017-beyond protein family and domain annotations","volume":"45","author":"Finn","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cmi.2019.07.026_bib21","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","article-title":"MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods","volume":"28","author":"Tamura","year":"2011","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.cmi.2019.07.026_bib22","first-page":"34","article-title":"[Clinical presentation of \u201cnew\u201d tick-borne borreliosis caused by Borrelia miyamotoi]","volume":"84","author":"Sarksyan","year":"2012","journal-title":"Ter Arkh"},{"key":"10.1016\/j.cmi.2019.07.026_bib23","first-page":"35","article-title":"[Clinical presentation of Ixodes tick-borne borreliosis caused by Borrelia miyamotoi in the context of an immune response to the pathogen]","volume":"89","author":"Platonov","year":"2017","journal-title":"Ter Arkh"},{"key":"10.1016\/j.cmi.2019.07.026_bib24","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cmi.2019.07.026_bib25","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s10096-014-2129-4","article-title":"Borrelia burgdorferi sensu lato serology in The Netherlands: guidelines versus daily practice","volume":"33","author":"Coumou","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19304185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19304185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:11:07Z","timestamp":1778519467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19304185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1198743X19304185"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.07.026","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}